BL 1871
Latest Information Update: 18 Nov 2003
At a glance
- Originator Bioglan Pharma [CEASED]
- Class Corticosteroids; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin disorders
Most Recent Events
- 03 Oct 2001 Phase-II clinical trials for Skin disorders in USA (Topical)